RP-BP-EF004: A 12-Month Open Label Safety Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Children Ages 4-5 Years Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical Trial Grant

Duke Scholars

Principal Investigator Scott Haden Kollins Psychiatry, Child & Family Mental Health & Community Psychia ...

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Rhodes Pharmaceuticals L.P.

Start Date

January 1, 2016

End Date

December 31, 2018

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Rhodes Pharmaceuticals L.P.

Start Date

January 1, 2016

End Date

December 31, 2018